Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 1-7

  Vaughan, Roxanne A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CALYCULIN A; COCAINE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; NORADRENALIN TRANSPORTER; OKADAIC ACID; PHORBOL 12 ACETATE 13 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOAMINO ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PHOSPHORUS 32; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PSYCHOSTIMULANT AGENT; SEROTONIN; SEROTONIN AGONIST; SEROTONIN TRANSPORTER; TETANUS TOXIN;

ANIMAL CELL; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; DEPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; MENTAL DISEASE; MUTAGENESIS; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; REVIEW; SCHIZOPHRENIA; SYNAPTOSOME;

ANIMALS; BIOLOGICAL TRANSPORT; DOPAMINE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVOUS SYSTEM DISEASES; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PHOSPHORYLATION; PROTEIN KINASE C; SEROTONIN; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS;

EID: 3042648050     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.052423     Document Type: Review

References (42)

1. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, and Blakely RD (1998) Acute regulation of norepinephrine transport: 1. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Therap 287:733-743.
2. Batchelor M and Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304-10309.
3. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, and Blakely RD (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571-7578.
4. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, and DeFelice LJ (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44:169-178.
5. Bonisch H, Hammermann R, and Bruss M (1998) Role of protein kinase C and second messengers in regulation of the norepinephrine transporters. Adv Pharmacol 42:183-186.
6. Carvelli L, Moron JA, Kahlig KM, Ferrer JV, Sen S, Lechleiter JD, Leeb-Lundberg LMF, Merrill G, Lafer EM, Ballou LM, et al. (2002) PI 3-Kinase regulation of dopamine uptake. J Neurochem 81:859-869.
7. Cervinski MA and Vaughan RA (2003) Methamphetamine-induced dopamine transporter phosphorylation is dependent on transport. Program No. 176.11 Society for Neuroscience Abstract/Viewer/Itinerary Planner. http://sfn. scholarone.com/ itin2003/index.html.
8. Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H, and Lee YS (2001) Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. J Neurochem 77:754-61.
9. Chi L and Reith MEA (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Therap 307:729-736.
10. Cowell RM, Kantor L, Keikilani Hewlett GH, Frey KA, and Gnegy ME (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur J Pharmacol 389:59-65.
11. Daniels GM and Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794-35801.
12. Daws LC, Callaghan PD, Moron JA, Kahlig KM, Shippenberg TS, Javitch JA, and Galli A (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290:1545-1550.
13. Fleckenstein AE, Metzger RR, Beyeler ML, Gibb JW, and Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838.
14. Foster JD, Blakely RD, and Vaughan RA (2003a) Mutational analysis of potential phosphorylation sites in the N-terminal tail of the rat dopamine transporter. Program No 167.12. Society for Neuroscience Abstract/Viewer/ Itinerary Planner. http://sfn.scholarone.com/itin2003/index.html.
15. Foster JD, Pananusorn B, Cervinski MA, Holden HE, and Vaughan RA (2003b) Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Mol Brain Res 110:100-108.
16. Foster JD, Pananusorn B, and Vaughan RA (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J Biol Chem 277:25178-25186.
17. Granas C, Ferrer J, Loland CJ, Javitch JA, and Gether U (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester and substance P receptor stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278:4990-5000.
18. Greengard P (2001) The neurobiology of slow synaptic transmission. Science (Wash DC) 294:1024-1030.
19. max. J Neurochem 68:225-232.
20. Jayanthi LD, Samuvel DJ, and Ramamoorthy S (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters: evidence for localization in lipid rafts and lipid raft mediated internalization. J Biol Chem 279:19315-19326.
21. Kantor L and Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598.
22. Kantor L, Hewlett GHK, Park YH, Richardson-Burns SM, Mellon MJ, and Gnegy ME (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016-1024.
23. Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, Gnegy ME, Galli A, and Javitch JA (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biology 2:387-393.
24. Lin Z, Zhang P-W, Zhu X, Melgari J-M, Huff R, Spieldoch RL, and Uhl GR (2003) Phosphatidylinositol 3-kinase, protein kinase C and MEK 1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites. J Biol Chem 278:20162-20170.
25. Loder MK and Melikian HE (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168-22174.
26. Melikian HE and Buckley KM (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699-7710.
27. Miller GW, Gainetdinov RR, Levey AI, and Caron MG (1999) Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20:424-429.
28. Moron JA, Zakharaova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, and Shippenberg T (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23:8480-8488.
29. Najib A, Pellicciioni P, Gil C, and Auilera J (2000) Serotonin transporter phosphorylation modulated by tetanus toxin. FEBS Lett 486:136-142.
30. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, and Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
31. Quick MW (2002) Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons. Int J Dev Neurosci 20:219-224.
32. Quick MW (2003) Regulating the conducting states of a mammalian serotonin transporter. Neuron 40:537-549.
33. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (Wash DC) 285:763-766.
34. Ramamoorthy S, Giovanetti SE, Qian Y, and Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273: 2458-2466.
35. Robinson MB (2002) Regulated trafficking of neurotransmitter transporters: Common notes but different melodies. J Neurochem 80:1-11.
36. Sakai N, Sasaki K, Nakashita M, Honda S, Ikegaki N, and Saito N (1997) Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases. J Neurochem 88:2618-2624.
37. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, and Fleckenstein AE (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 15:1413-1419.
38. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LFF, Carvelli L, Javitch JA, and Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850-6855.
39. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, and Blakely RD (2003) A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci 23:1697-1709.
40. Torres GE, Gainetdinov RR, and Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nature Rev Neurosci 4:13-25.
41. Vaughan RA, Huff RA, Uhl GR, and Kuhar MJ (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in rat striatum. J Biol Chem 272:15541-15546.
42. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors and signaling systems. Pharmacol Ther 92:21-55.